Medication Use Patterns for Osteoporosis: An Assessment of Guidelines, Treatment Rates, and Quality Improvement Interventions

Population-Based Fracture Risk Assessment and Osteoporosis Treatment Disparities by Race and Gender

“…These findings were similar to another study conducted among 8,909 older women in Alabama that found that African Americans were 0.4-fold as likely as Caucasians to receive BMD testing or osteoporosis medications, even after controlling for weight, income, insurance, glucocorticoid use, and prior fracture 26 . Consistent observations have been found in more selected populations, such as persons with prior fracture or long-term glucocorticoid users [27][28][29][30][31] . Although the reasons for undertreatment are likely varied, lack of uniformity in osteoporosis screening guidelines 32 and interpretation of BMD results for non-Caucasians 33-35 may contribute to the problem.…”

Treatment for older men with fractures

“…Their study, which included 76 published studies, was composed of similarly aged, mostly women, patients. They reported that patients seen by generalists were less likely than those seen by specialists to receive treatment, but they did not identify whether they considered obstetrician/gynecologists as generalists or specialists [39]. Because our study focused on men, we avoided the classification question associated with women's health providers.…”

Pharmacologic undertreatment of osteoporosis in Austrian nursing homes and senior's residences

“…During the past two decades signifi cant progress in the treatment of osteoporosis has been achieved [2][3][4]; at present several compounds with diff erent modes of action have been shown to reduce the risk of both vertebral and non-vertebral fractures [2,3]. Despite of this, only a small fraction of osteoporotic patients actually receive treatment [5][6][7][8][9][10].…”